Pharmacists scramble to protect remote communities from COVID-19
Clusters of infection in regional and remote areas continue to grow, with overworked pharmacists adapting their services to minimise the spread.
E-prescriptions, triptans and COVID-19 vaccines: your questions answered
In this monthly series, Australian Pharmacist speaks to the experts to answer some of your most frequently asked questions.
How pharmacy fared in this year’s Budget
The new federal government last night delivered its 2022–23 ‘bread and butter’ Budget amid a growing cost-of-living crisis.
Chronic pain – the role of pharmacists
Pharmacists play a vital role supporting patients with chronic pain.
Around 1 in 5 Australians experience chronic pain; this rises to 1 in 3...
Spironolactone for alcohol use disorder
The heart failure medicine has showed some promise in treating alcohol use disorder, through a different mechanism than existing treatments.
Expect an increase in demand for long-acting injectable buprenorphine
Changes to the Opioid Dependence Treatment program could make long-acting injectable buprenorphine the best option for many people.
